UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs ▼ | Disease Ontology |
---|---|---|---|---|---|
A0A7L1IXP6 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7L1IZ21 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7L1ILA3 | Angiotensin-converting enzyme (Fragment) |
|
3 | 0 |
|
A0A7L1IG95 | Cathepsin D (Fragment) |
|
2 | 0 |
|
A0A7L1IXY2 | GFRA1 protein (Fragment) |
|
2 | 0 |
|
A0A7L1J435 | N-acetylgalactosamine-6-sulfatase (Fragment) |
|
2 | 0 |
|
A0A7L1IYM0 | RET kinase (Fragment) |
|
1 | 0 |
|
A0A7L1IID8 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1J2V2 | GDNF family receptor alpha-2 (Fragment) |
|
2 | 0 |
|
A0A7L1IK41 | Voltage-dependent T-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1I955 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1JBU3 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7L1J816 | P2X purinoceptor (Fragment) |
|
1 | 0 |
|
A0A7L1IN85 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7L1IA74 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1I8R5 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7L1IKQ3 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1IUV1 | KCNKG protein (Fragment) |
|
1 | 0 |
|
A0A7L1ICZ1 | BACE2 secretase (Fragment) |
|
1 | 0 |
|
A0A7L1IWJ6 | Fibroblast growth factor receptor 2 (Fragment) |
|
8 | 0 |
|
A0A7L1IQU0 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1IGS7 | Fibroblast growth factor receptor 1 (Fragment) |
|
8 | 0 |
|
A0A7L1IQQ6 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7L1IJG1 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1JAI5 | Protein adenylyltransferase FICD (Fragment) |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024